miR‐146b Reverses epithelial‐mesenchymal transition via targeting PTP1B in cisplatin‐resistance human lung adenocarcinoma cells

Structure Identification of ViceninII Extracted from Dendrobium officinale and the Reversal of TGF-β1-Induced Epithelial–Mesenchymal Transition in Lung Adenocarcinoma Cells through TGF-β/Smad and PI3K/Akt/mTOR Signaling Pathways

(2019) Yingyi Luo et al.   MOLECULES

Resveratrol Protects Murine Chondrogenic ATDC5 Cells Against LPS-Induced Inflammatory Injury Through Up-Regulating MiR-146b

(2018) Hui Jin et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B

(2018) Feng Sun et al.   Cell Death & Disease

Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b

(2018) Sunglim Cho et al.   Nature Communications

Novel FHR fusion genes identified by MLPA and Western blot analysis

(2018) Gabriella Pitcher et al.   MOLECULAR IMMUNOLOGY

Pemetrexed plus cisplatin versus docetaxel plus cisplatin for stage IV lung adenocarcinoma based on propensity score matching

(2018) ShengFa Su et al.   ANTI-CANCER DRUGS

The role of exosomes and miRNAs in drug-resistance of cancer cells

(2017) Duc-Hiep Bach et al.   INTERNATIONAL JOURNAL OF CANCER

miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis

(2017) Helen Hermann et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

P2.01-012 Acquired Chemotherapy Resistance in vitro: miRNA Profiles of Chemotherapy Resistant Squamous Lung Cancer Cell Lines

(2017) Simon Haefliger et al.   Journal of Thoracic Oncology

MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma

(2017) Lipin Liu et al.   Molecular Cancer

Upholding a role for EMT in pancreatic cancer metastasis

(2017) Nicole M. Aiello et al.   NATURE

Exosome cargo reflects TGF-β1-mediated epithelial-to-mesenchymal transition (EMT) status in A549 human lung adenocarcinoma cells

(2016) Jiyeon Kim et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MiR-146 and miR-125 in the regulation of innate immunity and inflammation

(2016) Hye-Mi Lee et al.   BMB Reports

EMT, cell plasticity and metastasis

(2016) Christine L. Chaffer et al.   CANCER AND METASTASIS REVIEWS

Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis

(2016) Selma Masri et al.   CELL

TGF-β Tumor Suppression through a Lethal EMT

(2016) Charles J. David et al.   CELL

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

(2016) Martin Reck et al.   NEW ENGLAND JOURNAL OF MEDICINE

A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis

(2016) Xin Zhou et al.   Oncotarget

Long Noncoding RNA-LET Suppresses Tumor Growth and EMT in Lung Adenocarcinoma

(2016) Bin Liu et al.   Biomed Research International

Role of EMT in Metastasis and Therapy Resistance

(2016) Bethany Smith et al.   Journal of Clinical Medicine

Tumor Budding: The Name is EMT. Partial EMT.

(2016) Alexandru Grigore et al.   Journal of Clinical Medicine

PTP1B promotes cell proliferation and metastasis through activating src and ERK1/2 in non-small cell lung cancer

(2015) Hongbing Liu et al.   CANCER LETTERS

Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients

(2015) Na Wang et al.   CELL CYCLE

MiR-146b-5p Promotes Metastasis and Induces Epithelial-Mesenchymal Transition in Thyroid Cancer by Targeting ZNRF3

(2015) Xianzhao Deng et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

A Single miRNA-mRNA Interaction Affects the Immune Response in a Context- and Cell-Type-Specific Manner

(2015) Li-Fan Lu et al.   IMMUNITY

MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10

(2015) Ye Zhang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers

(2015) Ana I. Robles et al.   Journal of Thoracic Oncology

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

(2015) James Chih-Hsin Yang et al.   LANCET ONCOLOGY

microRNA (miRNA)-Mediated Pathogenetic Signaling in Alzheimer’s Disease (AD)

(2015) James M. Hill et al.   NEUROCHEMICAL RESEARCH

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

(2015) Edward B. Garon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

(2015) Julie Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

(2015) Hossein Borghaei et al.   NEW ENGLAND JOURNAL OF MEDICINE

Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer

(2015) J Niu et al.   ONCOGENE

Differential expression levels of plasma-derived miR-146b and miR-155 in papillary thyroid cancer

(2015) Yoon Se Lee et al.   ORAL ONCOLOGY

MicroRNA control of protein expression noise

(2015) J. M. Schmiedel et al.   SCIENCE

Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway

(2015) Tao Wu et al.   Drug Design Development and Therapy

High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer

(2015) Petra Leidinger et al.   Oncotarget

The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma

(2015) Jing Liu et al.   PLoS One

miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells

(2014) Jipeng Li et al.   Molecular Cancer

MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells

(2012) MENGRU CAO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY